¼¼¹Ì³ª/Çà»ç

> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç

Á¦¸ñ 2015³â 4¿ù 09ÀÏ »ý¹°Á¤º¸Çм¼¹Ì³ª
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2015-04-22

¼­¿ï´ëÇб³ »ý¹°Á¤º¸¿¬±¸¼Ò¿Í »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ °øµ¿ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿­°íÀÚ ÇÏ¿À´Ï,¡¡¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.

¡¡

ÀϽÃ: 2015³â¡¡4¿ù¡¡9ÀÏ ¸ñ¿äÀÏ ¿ÀÀü¡¡11½Ã

¿¬»ç:¡¡¹Ú Á¾ ÈÆ ±³¼ö´Ô¡¡(¼÷¸í¿©ÀÚ´ëÇб³ »ý¸í°úÇаú)

Àå¼Ò:¡¡¼­¿ï´ëÇб³¡¡25-1µ¿¡¡103È£

¡¡

Title:¡¡Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development

¡¡

Abstract:

Autosomal dominant polycystic kidney disease (ADPKD) is a common human genetic disease characterized by the formation of multiple fluid-filled cysts in bilateral kidneys. Although mutations in¡¡polycystic kidney disease 1¡¡(PKD1)¡¡are predominantly responsible for ADPKD, the focal and sporadic property of individual cystogenesis suggests another molecular mechanism such as epigenetic changes. To determine the epigenomic alterations in ADPKD and their functional relevance, ADPKD and non-ADPKD individuals were analyzed by unbiased methylation profiling genome-wide and compared with their expression data. Intriguingly,¡¡PKD1¡¡and other genes related to ion transport and cell adhesion were hypermethylated in gene-body regions, and their expressions were downregulated in ADPKD, implicating epigenetic silencing as the key mechanism underlying cystogenesis. Especially, in patients with ADPKD,¡¡PKD1¡¡was hypermethylated in gene-body region and it was associated with recruitment of methyl-CpG-binding domain 2 (MBD2) proteins. Moreover, treatment with DNA methylation inhibitors retarded cyst formation of Madin-Darby Canine Kidney (MDCK) cells, accompanied with the upregulation of¡¡Pkd1¡¡expression. These results are consistent with previous studies that knock-down of¡¡PKD1¡¡was sufficient for cystogenesis. Therefore, our results reveal a critical role for hypermethylation of¡¡PKD1¡¡and cystogenesis-related regulatory genes in cyst development, suggesting epigenetic therapy as a potential treatment for ADPKD.